Microglia and Astroglia—The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)

Abstract

Neuroinflammation is one of the postulated mechanisms for Pb neurotoxicity. However, the exact molecular mechanisms responsible for its pro-inflammatory effect are not fully elucidated. In this study, we examined the role of glial cells in neuroinflammation induced by Pb exposure. We investigated how microglia, a type of glial cell, responded to the changes caused by perinatal exposure to Pb by measuring the expression of Iba1 at the mRNA and protein levels. To assess the state of microglia, we analyzed the mRNA levels of specific markers associated with the cytotoxic M1 phenotype (Il1b, Il6, and Tnfa) and the cytoprotective M2 phenotype (Arg1, Chi3l1, Mrc1, Fcgr1a, Sphk1, and Tgfb1). Additionally, we measured the concentration of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α). To assess the reactivity and functionality status of astrocytes, we analyzed the GFAP (mRNA expression and protein concentration) as well as glutamine synthase (GS) protein level and activity. Using an electron microscope, we assessed ultrastructural abnormalities in the examined brain structures (forebrain cortex, cerebellum, and hippocampus). In addition, we measured the mRNA levels of Cxcl1 and Cxcl2, and their receptor, Cxcr2. Our data showed that perinatal exposure to Pb at low doses affected both microglia and astrocyte cells’ status (their mobilization, activation, function, and changes in gene expression profile) in a brain-structure-specific manner. The results suggest that both microglia and astrocytes represent a potential target for Pb neurotoxicity, thus being key mediators of neuroinflammation and further neuropathology evoked by Pb poisoning during perinatal brain development.

Deciphering Early and Progressive Molecular Signatures in Alzheimer’s Disease through Integrated Longitudinal Proteomic and Pathway Analysis in a Rodent Model

“…Future research should explore strategies to bolster mitochondrial function and oxidative stress resilience, offering a therapeutic avenue to mitigate AD progression. Our data also indicated alterations in proteins associated with neuroinflammation and glial cell activation, such as Glutamine Synthetase (Glul), predominantly expressed in astrocytes [ 47 , 48 ]. The role of glia in AD, especially astrocytes and microglia, has gained significant attention, with these cells implicated in both protective and degenerative processes within the AD brain [ 49 , 50 , 51 ].…”

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

“…Chronic neuro-inflammation is characterized by excessive activation of glial cells, including microglia and astrocytes. These cells release pro-inflammatory cytokines, chemokines, and ROS, which can worsen neuronal damage and lead to progressive neural deterioration seen in diseases such as AD, PD, HD, and MS (G ąssowska-Dobrowolska et al, 2023).…”

Proinflammatory microglial response is a common mechanism of Aroclor 1254- and Tetrabromobisphenol-A-induced neurotoxicity in immature chronically exposed rats

“…Activated microglial cells can induce detrimental neurotoxic effects by releasing proinflammatory factors (cytokines, prostaglandins) and oxidative stress factors (nitric oxide, reactive oxygen species) [44], thus contributing to the onset of inflammation and tissue damage in many brain disorders [11,45]. Under physiological conditions, when microglia are in a resting state, the expression of cytokines and chemokines in the CNS is low, but increases rapidly when exposed to various pathological stimuli [11], including toxic agents such as lead (Pb) [10,32]. Activated microglia also express cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS), which are important factors contributing to the inflammatory response.…”